1Fletcher CD, Berman J J, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol,2002,33:459-465.
2Hasegawa T, Matsuno Y, Shimoda T, et al. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and M1B-1 grade. Hum Patho1,2002,33:669-676.
3Miettinen M, E1-Rifai W, Sobin LH, et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol,2002, 33:478-483.
4Wang X, Mori J, Tang W, et al. Helpful parameter for malignant potential of gastrointestinal stromal tumors (GIST). Jpn J Clin Oncol, 2002,32 : 347-351.
5Rudolph P, Chiaravalli AM, Pauser U, et al. Gastrointestinal mesenchymal tumors- immunophenotypic classification and survival analysis. Virchows Arch,2002,441 : 238-248.
6Ignjatovic M. Gastrointestinal stromal tumors. Vojnosanit Pregl,2002,59 : 183-202.
7Rosai J. Ackerman surgical pathology.8th ed. New York: Mosby-Book Inc,1996. 645-693.
8Hirota S,Isozaki K,Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science, 1998,279:577-580.
9Emory TS, Sobin LH, Lukes L, et al. Prognosis of gastrointestinal smooth muscle (stromal) tumors: dependence on anatomic site. Am J Clin Pathol, 1995,154 : 53-60.
10Lewin KJ, Ridden RH, Weinstein WM, et al. Gastrointestinal pathology and its clinical implications. New York: lgaku-Shoin,1992. 284-341.
